Charlotte Derpoorter

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 6

Top Topics

Acute Myeloid Leukemia

Prognostic Factors

Long Noncoding Rna

Top Venues

International journal of molecular sciences

Pediatric blood & cancer

Pediatric hematology and oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Zhiyao Ren, Jolien Vanhooren, Charlotte Derpoorter, Barbara De Moerloose, Tim Lammens
A 69 long non-coding RNA signature predicts relapse and acts as independent prognostic factor in pediatric AML. Blood advances (2024)
Zhiyao Ren, Jolien Vanhooren, Charlotte Derpoorter, Barbara De Moerloose, Tim Lammens
A 69 long noncoding RNA signature predicts relapse and acts as independent prognostic factor in pediatric AML. Blood advances 8 (12) (2024)
Zhiyao Ren, Jolien Vanhooren, Charlotte Derpoorter, Barbara De Moerloose, Tim Lammens
A 69 long noncoding RNA signature predicts relapse and acts as independent prognostic factor in pediatric AML. Blood advances 8 (12) (2024)
Araceli Diez-Fraile, Joke De Ceulaer, Charlotte Derpoorter, Christophe Spaas, Tom De Backer, Philippe Lamoral, Johan Abeloos, Tim Lammens
Tracking the Molecular Fingerprint of Head and Neck Cancer for Recurrence Detection in Liquid Biopsies. International journal of molecular sciences 23 (5) (2022)
Charlotte Derpoorter, Ruben Van Paemel, Katrien Vandemeulebroecke, Jolien Vanhooren, Bram De Wilde, Geneviève Laureys, Tim Lammens
Whole genome sequencing and inheritance-based variant filtering as a tool for unraveling missing heritability in pediatric cancer. Pediatric hematology and oncology (2022)
Charlotte Derpoorter, Karl Vandepoele, Araceli Diez-Fraile, Katrien Vandemeulebroecke, Bram De Wilde, Frank Speleman, Nadine Van Roy, Tim Lammens, Geneviève Laureys
Pinpointing a potential role for CLEC12B in cancer predisposition through familial exome sequencing. Pediatric blood & cancer 66 (2) (2018)